CYLDRUNX1NSCLCtriple-negative breast cancerhead and neck cancernon-small cell lung cancer
…fy novel potential mediators, including LoF of TGFBR2 in NSCLC, CYLD in head and neck cancer, and RUNX1 in triple-negative breast ca…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CYLD ×
CYLD
This drug is selected. Its supporting articles are shown below.